In summary, LXRs are implicated in the protection against diabetes through modulation of glucose metabolism, β-cell insulin secretion, and inflammatory signaling, including recent developments indicating vasoprotection from hyperglycemia-induced endothelial dysfunction [50, 83]. The gene discussed is INS; the disease is diabetes mellitus.